OptiNose Future Growth
Future criteria checks 5/6
OptiNose is forecast to grow earnings and revenue by 70% and 27.9% per annum respectively while EPS is expected to grow by 71.6% per annum.
Key information
70.0%
Earnings growth rate
71.6%
EPS growth rate
| Pharmaceuticals earnings growth | 23.7% |
| Revenue growth rate | 27.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50
Nov 15
Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch
Sep 27Market Cool On OptiNose, Inc.'s (NASDAQ:OPTN) Revenues Pushing Shares 30% Lower
Aug 11Not Many Are Piling Into OptiNose, Inc. (NASDAQ:OPTN) Stock Yet As It Plummets 42%
Apr 27There's Reason For Concern Over OptiNose, Inc.'s (NASDAQ:OPTN) Massive 32% Price Jump
Mar 01Revenues Working Against OptiNose, Inc.'s (NASDAQ:OPTN) Share Price
Dec 28OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 29%
May 23The Consensus EPS Estimates For OptiNose, Inc. (NASDAQ:OPTN) Just Fell Dramatically
Mar 09OptiNose GAAP EPS of -$0.23 beats by $0.01, revenue of $20.6M misses by $0.9M
Aug 11OptiNose: Potential Winner In Chronic Sinusitis Treatment
Jun 16OptiNose: Underappreciated Potential
Mar 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 154 | 6 | 42 | 25 | 3 |
| 12/31/2025 | 121 | -13 | 22 | -1 | 4 |
| 12/31/2024 | 79 | -28 | -6 | -20 | 4 |
| 9/30/2024 | 76 | -31 | -40 | -40 | N/A |
| 6/30/2024 | 75 | -41 | -36 | -35 | N/A |
| 3/31/2024 | 74 | -31 | -32 | -32 | N/A |
| 12/31/2023 | 71 | -35 | -21 | -21 | N/A |
| 9/30/2023 | 72 | -41 | -45 | -45 | N/A |
| 6/30/2023 | 72 | -46 | -58 | -58 | N/A |
| 3/31/2023 | 73 | -68 | -59 | -59 | N/A |
| 12/31/2022 | 76 | -75 | -68 | -68 | N/A |
| 9/30/2022 | 78 | -75 | -67 | -67 | N/A |
| 6/30/2022 | 80 | -77 | -59 | -59 | N/A |
| 3/31/2022 | 77 | -82 | -68 | -68 | N/A |
| 12/31/2021 | 75 | -82 | -77 | -77 | N/A |
| 9/30/2021 | 68 | -91 | -80 | -79 | N/A |
| 6/30/2021 | 62 | -95 | -86 | -85 | N/A |
| 3/31/2021 | 54 | -97 | -87 | -86 | N/A |
| 12/31/2020 | 49 | -100 | -87 | -86 | N/A |
| 9/30/2020 | 44 | -101 | -86 | -85 | N/A |
| 6/30/2020 | 41 | -109 | -85 | -85 | N/A |
| 3/31/2020 | 37 | -110 | -90 | -89 | N/A |
| 12/31/2019 | 35 | -110 | -91 | -91 | N/A |
| 9/30/2019 | 27 | -111 | -94 | -93 | N/A |
| 6/30/2019 | 16 | -108 | -103 | -102 | N/A |
| 3/31/2019 | 11 | -105 | -100 | -99 | N/A |
| 12/31/2018 | 7 | -107 | -94 | -92 | N/A |
| 9/30/2018 | 4 | -101 | -88 | -85 | N/A |
| 6/30/2018 | 2 | -93 | N/A | -70 | N/A |
| 3/31/2018 | 1 | -81 | N/A | -51 | N/A |
| 12/31/2017 | N/A | -62 | N/A | -36 | N/A |
| 9/30/2017 | N/A | -43 | N/A | -28 | N/A |
| 6/30/2017 | N/A | -35 | N/A | -24 | N/A |
| 3/31/2017 | N/A | -46 | N/A | -24 | N/A |
| 12/31/2016 | 48 | 2 | N/A | 22 | N/A |
| 12/31/2015 | 0 | -40 | N/A | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPTN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: OPTN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OPTN is expected to become profitable in the next 3 years.
Revenue vs Market: OPTN's revenue (27.9% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: OPTN's revenue (27.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OPTN's Return on Equity is forecast to be high in 3 years time